Warberg Asset Management’s Biofrontera BFRIW Stock Holding History

Warberg Asset Management’s Portfolio BFRIW Stock Details BFRIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,451	Closed	-$10K	–	295
2022 Q2	$10K	Buy	+13,451	New	+$14.8K	﹤0.01%	207
2022 Q1	–	Sell	-18,487	Closed	-$67K	–	231
2021 Q4	$67K	Buy	+18,487	New	+$39.9K	0.01%	143

Other funds holding BFRIW

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Warberg Asset Management's BFRIW Position: Q3 2022 in Review

Warberg Asset Management sold out of Biofrontera (BFRIW) in Q3 2022, closing a stake of 13,451 shares — an estimated $10K sold.

Warberg Asset Management first reported a position in BFRIW in Q4 2021 and held it in 2 quarters. The position peaked at $67K in Q4 2021. 5 funds tracked by Wall St. Rank hold BFRIW as of Q3 2022.

Warberg Asset Management reported no remaining Biofrontera position as of Q3 2022 after selling out during the quarter.
Warberg Asset Management sold 13,451 Biofrontera shares in Q3 2022, an estimated $10K.
Warberg Asset Management first reported a position in Biofrontera in Q4 2021 and held it in 2 quarters.
Warberg Asset Management's Biofrontera position peaked at $67K in Q4 2021.
5 funds tracked by Wall St. Rank held Biofrontera as of Q3 2022.

Based on Warberg Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.